Following U.S. Stocks were among the “Top Losers” during Monday’s trade: Midstates Petroleum Company Inc (NYSE:MPO), Goodrich Petroleum Corporation (NYSE:GDP), RXi Pharmaceuticals Corp (NASDAQ:RXII), Paragon Offshore PLC (NYSE:PGN)
Their insights are depicted underneath:
Midstates Petroleum Company Inc (NYSE:MPO)’s shares dwindled -14.24%, and closed at $0.978, hitting new 52-week low of $0.95.
According to BUSINESS WIRE, Midstates Petroleum Company, Inc. (MPO), declared that Frederic (Jake) F. Brace will be joining the Corporation as a member of the Board of Directors (the “Board”) and an employee effective recently. In addition, the Corporation declared that Dr. Peter J. Hill has resigned from the Board effective recently and will resign from his current position as interim President and Chief Executive Officer right away following the filing of the Corporation’s annual report on Form 10-K. The Corporation intends to appoint Mr. Brace as interim President and Chief Executive Officer upon the effectiveness of Dr. Hill’s resignation. Dr. Hill will remain with the Corporation in a consulting role following Mr. Brace’s appointment. The Board has retained Korn Ferry, a leading global executive search firm, to assist the Corporation with the recruitment of a permanent Chief Executive Officer.
The Corporation also declared that the Board elected Alan J. Carr to the Board effective recently. Further, Board members Mary P. Ricciardello, Loren M. Leiker and Robert M. Tichio have indicated that they intend to resign preceding to the end of the month. In conjunction and concurrent with these Board resignations, the Board also intends to elect Bruce Stover and Robert Ogle to the Board.
Thomas Knudson, Chairman and Lead Director of the Board, commented, “On behalf of the Board, I would like to thank Dr. Hill and the other directors who are anticipated to be stepping down, for the dedication, commitment and contribution each has made to the Corporation. Dr. Hill has served the Corporation well, and I would like to commend him on his service. I would also like to extend a warm welcome to Messrs. Brace and Carr, and the others soon joining the Board, whose valuable experience will assist the Corporation address its current challenges and lead to sustained and long-term success. The Board looks forward to a smooth transition in connection with these planned administration changes and maintains its commitment to the long-term future of the Corporation.”
Midstates Petroleum Corporation, Inc. is an independent exploration and production corporation focused on the application of modern drilling and completion techniques in oil and liquids-rich basins in the onshore U.S. Midstates’ drilling and completion efforts are presently focused in the Mississippian Lime oil play in Oklahoma and Anadarko Basin in Texas and Oklahoma.
Goodrich Petroleum Corporation (NYSE:GDP) declined -13.62%, and closed at $2.98.
According to PRNewswire, The board of directors of Goodrich Petroleum Corp. (GDP), has declared a quarterly cash dividend of $0.6719 per share on its 5.375% Series B Cumulative Convertible Preferred Stock, with dividends to be paid on March 16, 2015 to stockholders of record as of March 2, 2015.
In addition, the Board has also declared a quarterly cash dividend of $0.625 per depositary share on its 10.00% Series C Cumulative Preferred Stock, and a quarterly cash dividend of $0.609375 per depositary share on its 9.75% Series D Cumulative Preferred Stock to be paid on March 16, 2015 to stockholders of record as of March 13, 2015.
Goodrich Petroleum Corporation is an independent oil and natural gas exploration and production corporation whose ordinary stock is listed on the New York Stock Exchange under the symbol GDP.
RXi Pharmaceuticals Corp (NASDAQ:RXII), dipped -13.33%, and closed at $1.30. With recent incline, the year-to-date (YTD) performance reflected a -16.67% decline below last year. During the past month the stock gain -0.78% brings three-month performance to -35.96% and six-month performance to -63.38%. The mean recommendation of analysts for this stock is 2.00. (where 1=Buy, 5=Sale).
RXi Pharmaceuticals Corporation, a biotechnology corporation, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform.
Paragon Offshore PLC (NYSE:PGN), dropped -13.21%, and closed at $1.38, hitting new 52-week low of $1.36. The company has the market capitalization of $134.76M. On the other hand the stock’s volatility for the week is 10.98%, and for the month is 11.22%. The stock price to book value is $0.26, however price to sale value is $0.06. Analyst’s mean recommendation regarding this stock is 3.00. (where 1=Buy, 5=Sale).
Paragon Offshore plc, together with its auxiliaries, provides offshore drilling rigs. The corporation is involved in contracting its rigs, related equipment, and work crews to conduct oil and gas drilling and workover operations for its exploration and production customers on a day rate basis. Its drilling fleet comprises of standard specification rigs comprising 34 jackups and 8 floaters, counting 5 drillships and 3 semisubmersibles, in addition to 1 floating production storage and offloading unit.
